The Effect of Xolair (Omalizumab) on Allergy Blood Cells

This study has been completed.
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Creighton University Identifier:
First received: April 8, 2008
Last updated: September 30, 2013
Last verified: September 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2007
  Primary Completion Date: October 2007 (Final data collection date for primary outcome measure)